Literature DB >> 23624711

Systemic vascular hemodynamic changes due to 17-β-estradiol intranasal administration.

Marco Matteo Ciccone1, Pietro Scicchitano, Michele Gesualdo, Fara Fornarelli, Vincenzo Pinto, Giuseppe Farinola, Rocco Lagioia, Marco Sassara, Annapaola Zito, Antonio Federici, Ettore Cicinelli.   

Abstract

PURPOSE: According to the literature, estradiol has a direct vasodilator action by means of endothelium-derived relaxing factor synthesis. The present study aims to evaluate the acute hemodynamic effects of intranasal 17-β-estradiol on cerebral and lower limb arterial circulation in postmenopausal women.
METHODS: Sixteen healthy women in natural menopause (mean age: 54 ± 3 years) were investigated for at least 6 months, each receiving 300 µg of intranasal 17-β-estradiol. We evaluated the heart rate, systolic/diastolic blood pressure, peak systolic velocity, end-diastolic velocity, and velocity-time integral (VTI) at the level of internal carotid and posterior tibial arteries, before and after 30, 60, and 180 minutes of drug administration.
RESULTS: After intranasal 17-β-estradiol administration, the internal carotid artery VTI showed statistically significant (P < .05) variations at all the time intervals after administration of the drug (30, 60, and 180 minutes) when compared with "time zero" (T0, ie, the speed recorded at baseline before drug administration). No significant variation was found at the posterior tibial artery. The systolic/diastolic blood pressure and heart rate did not significantly differ before and after drug administration.
CONCLUSIONS: The administration of a single intranasal dose of 17-β-estradiol in healthy postmenopausal women increased cerebral perfusions, whereas the effect on peripheral circulation was much more limited.

Entities:  

Keywords:  cerebral circulation; estradiol; estrogen therapy; menopause; peripheral circulation

Mesh:

Substances:

Year:  2013        PMID: 23624711     DOI: 10.1177/1074248413484385

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  5 in total

1.  Sleep and Premenstrual Syndrome.

Authors:  Shazia Jehan; Evan Auguste; Mahjabeen Hussain; Seithikurippu R Pandi-Perumal; Amon Brzezinski; Ravi Gupta; Hrayr Attarian; Giradin Jean-Louis; Samy I McFarlane
Journal:  J Sleep Med Disord       Date:  2016-08-03

2.  Cerebrovascular reactivity after cessation of menopausal hormone treatment.

Authors:  J N Barnes; R E Harvey; N A Eisenmann; K B Miller; M C Johnson; S M Kruse; B D Lahr; M J Joyner; V M Miller
Journal:  Climacteric       Date:  2019-01-21       Impact factor: 3.005

Review 3.  Modification of blood pressure in postmenopausal women: role of hormone replacement therapy.

Authors:  Marianna Cannoletta; Angelo Cagnacci
Journal:  Int J Womens Health       Date:  2014-08-11

4.  Intranasal 17β-Estradiol Modulates Spatial Learning and Memory in a Rat Model of Surgical Menopause.

Authors:  Alesia V Prakapenka; Veronica L Peña; Isabel Strouse; Steven Northup-Smith; Ally Schrier; Kinza Ahmed; Heather A Bimonte-Nelson; Rachael W Sirianni
Journal:  Pharmaceutics       Date:  2020-12-17       Impact factor: 6.321

5.  Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.

Authors:  Marianne Canonico; Laure Carcaillon; Geneviève Plu-Bureau; Emmanuel Oger; Archana Singh-Manoux; Pascale Tubert-Bitter; Alexis Elbaz; Pierre-Yves Scarabin
Journal:  Stroke       Date:  2016-06-02       Impact factor: 7.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.